Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (119)

2024

  1. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

2023

  1. A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

    ACS Nano, Vol. 17, Núm. 14, pp. 13811-13825

  2. A comparative NMR-based metabolomics study of lung parenchyma of severe COVID-19 patients

    Frontiers in Molecular Biosciences, Vol. 10

  3. Assessment of Regional Lung Ventilation with Positron Emission Tomography Using the Radiofluorinated Gas [18F]SF6: Application to an Animal Model of Impaired Ventilation

    Molecular Imaging and Biology, Vol. 25, Núm. 2, pp. 413-422

  4. Author Correction: γ-Linolenic acid in maternal milk drives cardiac metabolic maturation (Nature, (2023), 618, 7964, (365-373), 10.1038/s41586-023-06068-7)

    Nature

  5. Benchtop NMR-Based Metabolomics: First Steps for Biomedical Application

    Metabolites, Vol. 13, Núm. 5

  6. Biomimetic and Functional Nanomaterials for Molecular Imaging

    Pharmaceutics

  7. Comparison of Algorithms to Compute Relaxation Time Maps in Magnetic Resonance Imaging

    Applied Sciences (Switzerland), Vol. 13, Núm. 7

  8. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  9. Design and fabrication of a microfluidic system with embedded circular channels for rotary cell culture

    Biotechnology Journal, Vol. 18, Núm. 7

  10. Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets

    Frontiers in Cardiovascular Medicine

  11. Editorial: Rising stars in cancer metabolism 2022

    Frontiers in Oncology

  12. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  13. Luminescent Carbon Nanodots Doped with Gadolinium (III): Purification Criteria, Chemical and Biological Characterization of a New Dual Fluorescence/MR Imaging Agent

    Small, Vol. 19, Núm. 31

  14. Machine Learning-Assisted High-Throughput SERS Classification of Cell Secretomes

    Small, Vol. 19, Núm. 51

  15. Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

    ACS Applied Nano Materials, Vol. 6, Núm. 22, pp. 20523-20538

  16. γ-Linolenic acid in maternal milk drives cardiac metabolic maturation

    Nature, Vol. 618, Núm. 7964, pp. 365-373

2022

  1. 2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart

    Scientific reports, Vol. 12, Núm. 1, pp. 6890

  2. A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents

    ACS Omega, Vol. 7, Núm. 42, pp. 36905-36917

  3. Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis

    Transboundary and Emerging Diseases, Vol. 69, Núm. 4, pp. e859-e870